Zhang Jianzhong, Xia Yutian, Liu Xuan, Liu Gang
Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361102, China.
Innovation Center for Cell Biology, State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen 361102, China.
Bioengineering (Basel). 2023 Jan 22;10(2):148. doi: 10.3390/bioengineering10020148.
Vaccination is the most cost-effective means in the fight against infectious diseases. Various kinds of vaccines have been developed since the outbreak of COVID-19, some of which have been approved for clinical application. Though vaccines available achieved partial success in protecting vaccinated subjects from infection or hospitalization, numerous efforts are still needed to end the global pandemic, especially in the case of emerging new variants. Safe and efficient vaccines are the key elements to stop the pandemic from attacking the world now; novel and evolving vaccine technologies are urged in the course of fighting (re)-emerging infectious diseases. Advances in biotechnology offered the progress of vaccinology in the past few years, and lots of innovative approaches have been applied to the vaccine design during the ongoing pandemic. In this review, we summarize the state-of-the-art vaccine strategies involved in controlling the transmission of SARS-CoV-2 and its variants. In addition, challenges and future directions for rational vaccine design are discussed.
疫苗接种是对抗传染病最具成本效益的手段。自新冠疫情爆发以来,已研发出多种疫苗,其中一些已获批用于临床。尽管现有疫苗在保护接种者免受感染或住院方面取得了部分成功,但仍需要付出诸多努力来结束全球疫情,尤其是在出现新变种的情况下。安全有效的疫苗是目前阻止疫情袭击全球的关键要素;在抗击(再)出现的传染病过程中,迫切需要新颖且不断发展的疫苗技术。生物技术的进步推动了疫苗学在过去几年的发展,在当前疫情期间,许多创新方法已应用于疫苗设计。在本综述中,我们总结了用于控制SARS-CoV-2及其变种传播的最新疫苗策略。此外,还讨论了合理疫苗设计面临的挑战和未来方向。